Concentrix CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation reported a significant net loss of $1.28 billion for fiscal year 2025, primarily driven by a $1.52 billion goodwill impairment charge, despite a 2.2% revenue increase.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's 2024 annual report details a year of significant growth, driven by strategic acquisitions and investments in technology, while also navigating economic and industry challenges.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's 10-K filing details the company's common stock, preferred stock authorization, anti-takeover provisions, and liability limitations for directors and officers.